NCT02918006: A trial that was reported late by Vaxart
This trial has reported, although it was 693 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02918006 |
|---|---|
| Title | Phase 2 Randomized, Controlled, Human Influenza A (H1N1) Challenge Study Following Administration of an Oral H1N1 HA Adenoviral-Vector Based Seasonal Influenza Vaccine and dsRNA Adjuvant to Healthy Adult Volunteers |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Aug. 31, 2016 |
| Completion date | Aug. 8, 2017 |
| Required reporting date | Aug. 8, 2020, midnight |
| Actual reporting date | July 2, 2022 |
| Date last checked at ClinicalTrials.gov | April 17, 2026 |
| Days late | 693 |